Genmab — August 2018
-
Jeg skal ikke have så mange flere. Men sover tilgengæld godt med pengene i GEN. BlockRock havde 5,03% i Nov 2017 så de har solgt ca. 55.000 stk alt andet lige. Det kan Nordea sælge hurtigere. Kan det være lidt sektor rotation eller de tager lidt top af deres aktier? Negativ signalværdi ihvertfald.
-
Hvis du ser bort fra nettosælger Helge, så er det fuldstændig korrekt. Lad os se de kommende dage. Stærke MAIA data skal nok vende trenden.
-
Nettosalg skulle der stå
-
The FDA limited the use of two cancer drugs Merck’s Keytruda (pembrolizumab) and Roche’s Tecentriq (atezolizumab) and updated their labeling to reflect the new limitations.
The agency decided to restrict the drugs because of decreased survival associated with their use as monotherapies compared to platinum-based chemotherapy in clinical trials to treat metastatic urothelial cancer patients
-
God morgen
-
God morgen.
-
-
God morgen
-
Godmorgen, På gårsdagens Q&A svarede JVdW at Janssen er i gang med at teste DARA i raske frivillige inden der evt. opstartes studier i autoimmune sygdomme (RA). Hvad er det mere præcis man tester - eftersom mange patienter er behandlet kan det næppe være safety. Og virkning vel heller ikke da det er raske frivillige. ???
-
Tolerability, Pharmacokinetics and Pharmacodynamics https://www.clinicaltrials.gov/ct2/show/NCT03320707?term=daratumumab+healthy&rank=1
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind